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Coxiella burnetii is an obligate intracellular bacterial pathogen res-
ponsible for acute and chronic Q fever. This bacterium harbors a
type IV secretion system (T4SS) highly similar to the Dot/Icm of
Legionella pneumophila that is believed to be essential for its in-
fectivity. Protein substrates of the Coxiella T4SS are predicted to
facilitate the biogenesis of a phagosome permissive for its intracel-
lular growth. However, due to the lack of genetic systems, protein
transfer by the C. burnetii Dot/Icm has not been demonstrated. In
this study, we report the identification of 32 substrates of the C.
burnetii Dot/Icm system using a fluorescence-based β-lactamase
(TEM1) translocation assay as well as the calmodulin-dependent
adenylate cyclase (CyaA) assay in the surrogate host L. pneumo-
phila. Notably, 26 identified T4SS substrates are hypothetical pro-
teins without predicted function. Candidate secretion substrates
were obtained by using (i) a genetic screen to identify C. burnetii
proteins interacting with DotF, a component of the T4SS, and
(ii) bioinformatic approaches to retrieve candidate genes that har-
bor characteristics associated with previously reported substrates
of the Dot/Icm system from both C. burnetii and L. pneumophila.
Moreover, we have developed a shuttle plasmid that allows the
expression of recombinant proteins in C. burnetii as TEM fusion
products. Using this system, we demonstrated that a Dot/Icm sub-
strate identified with L. pneumophila was also translocated by C.
burnetii in a process that requires its C terminus, providing direct
genetic evidence of a functional T4SS in C. burnetii.
effectors | protein translocation | transporter
Specialized protein transport systems play essential roles in theestablishment of symbiotic or pathogenic interactions between
microorganisms and their hosts. Among these, a conjugationre-
lated T4SS has been found in the highly adapted pathogen Coxiella
burnetii, an obligate intracellular Gram-negative bacterium that
replicates inside alveolar mononuclear phagocytes and causes
acute and chronic Q fever in humans (1). Unlike other intracel-
lular bacteria that use mechanisms to evade endocytic pathways,
C. burnetii has a unique intracellular life cycle. After internal-
ization into a host cell, C. burnetii establishes a parasitophorous
vacuole (PV) that eventually fuses with compartments of the
lysosomal network and expands to occupy the majority of the
cytoplasmic space within the infected cell (2).
The putative T4SS inC. burnetii consists of 23 of the 26Dot/Icm
proteins found in Legionella pneumophila, the causative agent of
Legionnaires’ disease (3). The high similarity between these two
transport systems has allowed the use of genetic tools available
in Legionella to dissect the function of the C. burnetii secretion sys-
tem. Some C. burnetii dot/icm genes are capable of complementing
corresponding mutations in L. pneumophila, suggesting that the
Coxiella T4SS is active (4). Various strategies have led to the iden-
tificationofmore than150protein substrates for theL.pneumophila
T4SS (5–7). These proteins are predicted to modulate various host
processes, including apoptosis, ubiquitination (8–10), lipid metab-
olism, and membrane trafficking (6, 11–13). By combining bio-
informatics tools with the use of Legionella as a surrogate host to
measure protein translocation, 11 Coxiella proteins containing the
ankyrin repeat motif have been identified as substrates of its Dot/
Icm transporter (11, 14).
The genome of C. burnetii and the potential number of genes
that it encodes are significantly smaller than those of L. pneumo-
phila (3). However, given the diverse challenges that the bacterium
faces in the intracellular environment, it is likely that additional
Dot/Icm protein substrates are present in the C. burnetii genome.
To obtain a more complete inventory of substrates transferred by
the Dot/Icm system of C. burnetii, we initiated a study to identify
such proteins by dual strategies that combined genetic screenings
and bioinformatics analyses. Because a subset of Legionella Dot/
Icm substrates specifically interacts with DotF (5), an important
component of the T4SS that localizes to the inner membrane of
the bacterium (15). We hypothesized that similar interactions
occur between Coxiella T4SS substrates and its DotF protein. In
addition, in L. pneumophila, expression of some effectors is cor-
egulated with some dot/icm genes, and the genetic elements of
such regulatory circuits have been identified (16, 17). Finally, it has
been shown that proteins with motifs and structural features spe-
cific for eukaryotic cells are more likely to be effectors (7, 14).
Thus, we have used a bacterial two-hybrid screening and bio-
informatics analyses to search for Coxiella proteins that fit one or
more of these features. Our efforts with these strategies have led to
the retrieval of 57 C. burnetii T4SS substrate candidates. Using
independent translocation assays based on the Cya (18) or the
β-lactamase (TEM1)–mediated FRET on CCF4-AM (6, 19), we
demonstrated that 32 of these proteins are translocated into host
cells by the L. pneumophila Dot/Icm system.
One of the biggest obstacles in the study of obligate intra-
cellular pathogens such as C. burnetii is the inability to perform
genetic manipulations, making it difficult to directly examine the
function of identified virulence factors. In this study, we have
generated a C. burnetii shuttle vector using the backbone of the
IncQ group plasmid RSF1010, which can be stably maintained
under selection after introduction by electroporation. Using this
vector, we demonstrated that β-lactamase fusion proteins can
be expressed in C. burnetii. Furthermore, we demonstrated that
C. burnetii is capable of transferring substrates into host cells in
a manner that requires the C-terminal portion of the proteins,
providing genetic evidence for the first time that C. burnetii has
a functional T4SS.
Results
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of type IVb apparatus, has been successfully used as bait to identify
at least eight Legionella T4SS substrates (5). Bioinformatics and ex-
perimental evidence indicates extensive homology between L. pneu-
mophila and C. burnetii T4SS (3). Therefore, we used a bacterial two
hybrid screen (20) to identify C. burnetii proteins that specifically in-
teract with DotF. Fragments of C. burnetii DNA were inserted into
pUT18 plasmid to construct a genomic library. After cotransforming
the Escherichia coli strain BTH101 (20) expressing bait with plasmid
DNA harboring a C. burnetii library, we used LB X-gal plates or
synthetic medium with lactose as the sole carbon source to monitor
Lac+ phenotypes. Clones with interactions significantly higher than
the background (Fig. 1A) were sequenced and analyzed. From
∼100,000 colonies, we identified 25 distinct orfs that were fused in-
frame with the Bordetella pertussis adenylate cyclase T18 fragment.
Several genes were identified independently more than one time
(Table S1). Notably, another inner membrane-anchored Dot/Icm
component, IcmO, was identified multiple times, which suggests
a specific interaction between DotF and IcmO. Of the 25 identified
genes, 11 candidates were eliminated from further analysis based on
their predicted function and conservation among Gram-negative bac-
teria (Table S1).
To determine whether the DotF-binding proteins can be deliv-
ered into host cells by the Dot/Icm system of the surrogate host
L. pneumophila, we used two different methods, CyaA (18) and
TEM1 translocation assays (6). We found that six of 14 proteins could
be transferred into host cells in both assays in a Dot/Icm-dependent
manner (Figs. 1B and 2). Furthermore, translocation of several se-
lected proteins was also confirmed by SidCΔC100 fusion translocation
assays (21) (Fig. 1 C and D). All proteins found to be positive in one
assay were also positive in all assays listed, indicating consistency
among methods. These results indicate that some C. burnetiiDot/Icm
substrates interact with type IV component proteins during trans-
location. Using DotF as bait in a genome-wide preliminary screen led
to a validation rate of 42.8% (6/14) for the T4SS substrates, which is
severalfold higher than an estimate of total substrates predicted from
the C. burnetti genome based on the number of effectors predicted
from L. pneumophila (5–10%) (7).
Genome-Wide Bioinformatic Analysis to Identify Putative C. burnetii
Dot/Icm Substrates. Based on recent studies, bioinformatic prediction
is a promising and effective approach to identify putative bacterial
effectors, particularly when a considerable number of validated effec-
tors has been identified by other methods. By using appropriate cri-
teria, computational methods can dramatically narrow the number of
potential targets, resulting in a reduction in subsequent experimental
validation. Based on the successful application of bioinformatics-
guided approaches in identifying L. pneumophila Dot/Icm effector
proteins (7), we used a similar strategy to search for C. burnetii Dot/
Icm effector candidates. Several studies with L. pneumophila sug-
gested that someDot/Icm effectors have one ormore paralogs present
in theL. pneumophila genome, which are believed to confer functional
redundancy within effector families (5, 22). It is reasonable to spec-
ulate that some effectors in L. pneumophila and C. burnetii have
similar targets in the host cell during infection. We performed a ge-
nomic search for paralogs of the reported 134 L. pneumophila and
nine C. burnetii T4SS substrates (Table S2). By using a cutoff of
expected value (E) <0.01, we obtained 27 C. burnetii proteins with
varying degrees of similarity (E = 7e−3 to 1e−95) to known T4SS
substrates. Of these 27 orfs, one Dot/Icm component protein IcmE
and 11 ankyrin repeat family proteins, which have been characterized
in previous studies (11, 14), were eliminated. The remaining 15 orfs
were retained for experimental validation (Table S2).
Proteins containing the Fic (filamentation-induced by c-AMP) do-
main involved in posttranslational modification of target molecule by
ampylation represent a recently identified class of virulence factors
and have been found inVibrio parahaemolyticus,Histophilus somni and
L. pneumophila (23–25). Three Coxiella proteins that contain the core
sequence (HPFx[D/E]GN[G/K]R) of the Fic motif (26) were retrieved
and included in the candidate pool (Table S3).
Zusman et al. showed that the two-component regulatory system
component, PmrA, may directly regulate Dot/Icm type IV expression
Fig. 1. Several DotF interactingproteins are
translocated substrates of the L. pneumo-
phila Dot/Icm system. (A) Interactions be-
tween C. burnetii DotF and substrates of its
T4SS assayed by the bacterial two-hybrid sys-
tem. E. coli strain BTH101 containing the in-
dicated plasmids were grown to exponential
phase with 100 nM IPTG at 28 °C in LB broth.
An appropriate volume was withdrawn for
β-galactosidase assay. β-Galactosidase activity
was expressed as Miller units. Experiments
were performed three independent times.
Data shown are from one representative ex-
periment. **P < 0.01. (B) Wild-type (wt)
L. pneumophila strain Lp02 (graybar) and the
dotAmutant strain Lp03 (white bar) harbor-
ing the CyaA fusion proteins were used to
infectdifferentiatedU937cellsatMOI30,and
the cAMP level of infected cells was de-
termined. A previously validated effector
protein ankG (CBU0781) (11, 14) was used as
positive control. Each bar represents the av-
erage cAMP value obtained from triplicate
wells±SD. (CandD)DotF interactingproteins
mediated translocation of the transfer de-
ficient SidCΔC100 into macrophages. Mouse
macrophages were infected with L. pneu-
mophilaexpressingSidC (pZL199), SidCΔC100
(pZL204), SidCΔC100::CBU1825 (pZL204-
CBU1825), SidCΔC100::CBU0781 (pZL204-
CBU0781), SidCΔC100::CBU0209 (pZL204-
CBU0209), or SidCΔC100::CBU1751 (pZL204-
CBU1751) for 1 h; L. pneumophila and SidC
were differentially labeled with distinctive antibodies as previously described (21). At least 150 vacuoles in triplicate samples were scored in each experiment. Repre-
sentative images from individual assay wells are shown in D. Bacteria are labeled in green, and SidC is stained in red. **P < 0.01 to pZL204.
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in L. pneumophila and C. burnetii (17). In addition, they predicted 68
C. burnetii orfs that contain putative PmrA response elements by the
presence of the consensus sequence TTAA-N6-TTAA. We examined
the −200 to 0 bp of all C. burnetii Dot/Icm component genes and of
experimentally verifiedC. burnetiiDot/Icm substrate genes (11, 14) for
PmrA consensus sequences. Along with five dot/icm genes (icmD,
icmQ, icmV, icmW, and dotD), several genes encoding ankyrin repeat
domain-containing proteins (14) (AnkB, AnkJ, and AnkM), one gene
encoding a DotF-binding protein (CBU1751), and five of 15 effector
paralogs (Table S3) were found to contain similar PmrA responding
elements (Fig. S1A). Interestingly, one nucleotide from the putative
PmrA responding element upstream of ankJ and ankM was distinct
from the consensus sequence suggested by Zusman et al. (17). This
discrepancy is consistent with the notion that PmrA responding ele-
ments do not have strict sequence requirements in certain positions
(27). We postulated that the C. burnetii PmrA-dependent regulon
might contain additional unidentified targets, and that some of these
targets could be substrates of C. burnetii T4SS. To screen all orfs po-
tentially regulated by PmrA, we first constructed a PmrA-binding
motif model by using sequence information of PmrA-responsive C.
burnetii dot/icm genes and verified Dot/Icm substrate genes (Fig. S1B).
Using thresholds described in Materials and Methods, we performed
a genome-wide search of C. burnetii with this PmrA-binding motif
model and obtained 126 orfs (Table S4).
Bacterial pathogens can acquire virulence factors such as effectors
by convergent evolution or by horizontal gene transfer (6, 28, 29).
Some of the genes presumably acquired from eukaryotic cells still
contain structural features typical for eukaryotic proteins. In agree-
ment with this notion, C. burnetii encodes an abundance of eukary-
otic-like proteins in its genome (14). These proteins more likely
function in eukaryotic cells by targeting various host processes to
allow successful infection, making them strong candidates for Cox-
iella T4SS effectors. Indeed, among the 126 putative PmrA-regulated
genes, 35 encode proteins with eukaryotic domains implicated in
protein–protein interactions (Table S3). After exclusion of all
ankyrin domain-containing proteins, which have been previously
analyzed for Dot/Icm translocation (11, 14), 24 novel orfs were
retained for experimental validation (Table S3).
Dot/Icm-Dependent Translocation of C. burnetii Proteins Predicted by
Bioinformatics Analyses. To determine whether any of the bio-
informatically predicted C. burnetii proteins are substrates of the
Dot/Icm system, we tested 15 effector paralogs, three Fic motif-
containing proteins, and 24 putative PmrA-regulated eukaryotic
domain-containing proteins using the TEM1 translocation assay in
L. pneumophila. We fused each of the 42 orfs to the C-terminal end
of TEM1 protein. L. pneumophila strains expressing these fusions
were used to challenge differentiated U937 cells. Three hours after
uptake, CCF4-AM was loaded into infected monolayers. In these
experiments, samples infected by strains harboring fusions of the
L. pneumophila RalF displayed 95% blue cells, whereas no blue cells
were detected in infections receiving the strain carrying the empty
plasmid. We considered a protein to be a substrate of the Dot/Icm
system if more than 1% of U937 cells emit blue fluorescence after
3 h incubation with WT L. pneumophila (Lp02) but not with the
DotA-deficient mutant (Lp03) expressing the same fusion protein.
These experiments revealed that 26 of the 42 candidates are trans-
located by L. pneumophila in a Dot/Icm-dependent manner (Fig. 2).
Among these, nine proteins are from the 15 Dot/Icm effector
paralogs and 16 are from the 24 putative PmrA-regulated eukaryotic
domain-containing proteins (Tables S3 and S5). CBU2078, one of
the three Fic motif-containing proteins, can also be translocated
(Table S5). We also examined the steady-state protein levels of all
fusions in L. pneumophila by immunoblot using a β-lactamase spe-
cific antibody. In most strains, the fusion proteins were expressed at
a comparable level, indicating that the negative translocation results
in infections using these strains were not caused by low-level ex-
pression of the fusion proteins (Fig. S2A). These results also indicate
that there is no clear correlation between transfer efficiency and
levels of the fusion protein in the bacterial cells. Thus, a large frac-
tion (26/42) of the bioinformatically predicted C. burnetii proteins are
Dot/Icm substrates. The success of identifying substrates using the
putative PmrA-binding element suggests that expression of some of
these genes may regulated by this two-component system.
C. burnetii Is Capable of Translocating into Host Cells Substrates
Identified with the L. pneumophila Heterologous Expression
System. The fact that some dot/icm genes from C. burnetii were able
to complement corresponding L. pneumophila mutants suggests that
the T4SS in Coxiella is active (4). However, there has been no direct
experimental evidence demonstrating the activity of the C. burnetii
Dot/Icm system. To address this problem, we first developed a system
for expressing recombinant proteins in C. burnetii. Vectors derived
from the IncQ plasmid RSF1010 are capable of replicating in a wide
range of bacterial species and were the basis of the first vectors used in
the genetic studies of L. pneumophila pathogenesis (30). Thus, we
modified pJB908 (18), a derivative of RSF1010 (30), by inserting an
mCherry-CmR selection marker cassette (mChcat cassette). The re-
sultant plasmid, pKM230 (Fig. 3A), was used to transform C. burnetii.
Transformed bacterial cells were then used to infect mammalian cells.
Approximately 3–4 wk after infection, mCherry-expressing bacteria be-
came visible in all cultures (Fig. 3B). We rescued the shuttle vector by
transformation of E. coli strain TOP10 with total C. burnetii DNA
isolated from infected cells. Furthermore, the hybridization pattern
obtained with the mCherry-specific probe confirmed the presence of
pKM230 in C. burnetii (Fig. 3C). Finally, with the recently developed
semisolid ACCM agarose plates (31), we were able to isolate and
propagate C. burnetii from single colonies (Fig. 3D). These results
demonstrate that we have successfully developed a plasmid that can
stably replicate in C. burnetii.
The success in the development of a shuttle vector (pKM230)
allowed us to examine whether C. burnetii is able to translocate one or
more Dot/Icm substrates identified with L. pneumophila heterologous
expression. We constructed another shuttle vector, pCBTEM, which
allows use of the TEM translocation assay in both L. pneumophila and
C. burnetii using origins of pXDC61 (6) and pKM230. The orf of
CBU1825 was inserted into the 3′ end of the β-lactamase gene to
generate CBU1825-pCBTEM. After transformation into C. burnetii,
Fig. 2. Dot/Icm-dependent translocation of C. burnetii proteins into U937
cells by L. pneumophila. WT L. pneumophila strain Lp02 and dotA mutant
strain Lp03-expressing TEM1 fusion proteins were used to infect differenti-
ated U937 cells at anMOI of 30. Infected cells were loaded with CCF4/AM and
translocation was determined by counting the percentage of cells with 450
nm emission (with cleaved CCF4/AM). At least 400 events in triplicate samples
were scored for each experiment. Representative images from individual
assay wells are shown on the right. The results shown represent the average
of two or three experiments.
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single colonies were isolated from semisolidACCMagarose plates and
propagated in liquid ACCM for 1–2 mo. After induction with 1 mM
IPTG for 3 d to induce the expression of the fusion protein, bacteria
were purified fromACCM.By immunoblotting using anti–β-lactamase
antibodies, we showed that the fusion protein of predicted molecular
mass was produced in C. burnetii (Fig. 4A).
To test protein translocation by C. burnetii, we infected THP-1 cells
with anMOIof 30 for 24h and then loaded the sampleswithCCF4/AM
for 8 h at room temperature. Whereas infections with bacteria har-
boring the empty vector pCBTEM did not cause any cell to emit blue
fluorescence, ≈37% blue fluorescent cells were detected in samples
infected with aC. burnetii strain expressing the TEM-CBU1825 fusion,
indicating that CBU1825 was capable of promoting the transfer of
the fusion protein into the cytoplasmof THP1 cells (Fig. 4B andC). To
verify theDot/Icm substrates identified withL. pneumophila, fivemore
orfs (CBU0129, CBU0881, CBU1569, CBU1823, and CBU2052) were
tested inC. burnetii. All of themwere capable of transferring the fusion
protein into the cytoplasm of THP1 cells (Fig. S2B). These results in-
dicate that during infection, C. burnetii is able to translocate protein
substrates into host cells via the Dot/Icm T4SS.
C-Terminal End of Substrate Is Critical for Protein Translocation by
C. burnetii. Although the exact features important for Dot/Icm-de-
pendent protein translocation are unknown, signal motif essential for
protein translocation by the Dot/Icm system of L. pneumophila have
been mapped to the C termini of its substrates (32). Voth et al. sug-
gested that the C-terminal portion of C. burnetiiDot/Icm substrates is
also required for efficient translocation by L. pneumophila (14). To
determine the importance of the C terminus of C. burnetii Dot/Icm
substrates in their translocation, we created a CBU1825 mutant that
lacked the coding capacity for the last 20 amino acids of the protein
and tested its translocation in L. pneumophila and C. burnetii. The
β-lactamase fusion protein of this mutant was stably expressed in
C. burnetii (Fig. 4A 1825ΔC20-pCBTEM). However, this mutant was
unable to promote the delivery of the fusion protein into host cells, as
no blue fluorescence cells were detected (Fig. 4 B and C). Similarly,
no translocation was observed in macrophages infected by L. pneu-
mophila expressing this fusion (Fig. S2C). To confirm that the trans-
location signal is located at C terminus of CBU1825, we created
a truncated CBU1825 that encode for the last 50 amino acids of the
protein. As we expected, this truncated CBU1825C50 was well
expressed in C. burnetii (Fig. 4A 1825C50-pCBTEM) and partially
restored the translocation capacity of the full length CBU1825 in both
C. burnetii and L. pneumophila (Fig. 4 B and C and Fig. S2C). These
results indicate that, similar to other T4SS, the C-terminal end of
these C. burnetii Dot/Icm substrates contains a translocation signal,
further supporting the hypothesis of T4SS-dependent translocation
of β-lactamase fusion proteins in C. burnetii.
C. burnetii Dot/Icm Substrates Localize to Distinct Subcellular Regions
When Expressed Ectopically in Mammalian Cells. Upon being trans-
located into host cells, bacterial effectors often target specific host
organelles to fulfill their physiological functions (6, 11, 14). To gain
insights into these identified C. burnetii effector proteins, we con-
structed GFP fusions of these proteins and expressed each in Vero
cells by transient transfection. Whereas many of these fusions
appeared to be cytosolic in patterns indistinguishable from that
of GFP alone, 12 fusions displayed distinct distribution patterns.
For example, CBU1314 exclusively localized to nuclei, which was
evidenced by colocalization with the DNA labeling dye Hoechst
(Fig. S3). On the other hand, CBU1543, CBU1825, and CBU0801
displayed punctuate structures that associated with undefined vesic-
ular compartments. CBU1556 was excluded from nuclei and showed
filament structure throughout the cytoplasm (Fig. S3). Localization of
these proteins to distinct host organelles adds strong support to the
notion that many of these proteins are bona fide effectors that
function to manipulate host processes in specific subcellular sites.
Discussion
It is well established that effector proteins of intracellular bacterial
pathogens play essential roles in infection and the development of
disease (33, 34). Functional analysis of effectors holds great promise in
the study of pathogenesis, especially in the elucidation of host cellular
pathways, which are either essential or co-opted by the pathogen.
However, the lack of genetic tools for obligate intracellular pathogens
has made the identification of their effectors a daunting task. In this
study, by combining genetic screening and bioinformatic analysis, we
obtained a large collection of candidate protein substrates for the
C. burnetii Dot/Icm T4SS. The use of L. pneumophila as a surrogate
host led to the identification of 32 proteins that were translocated into
host cells in a Dot/Icm-dependent manner. Interestingly, two of the
identified Dot/Icm substrates (CBU1314 and CBU1823) are suggested
to localize in the cytoplasm of C. burnetii infected Vero cells (by mass
spectrometry) (35). Although the biological significance of the in-
teraction between protein substrates and components of the transport
system is largely undefined, such interactions have been very useful in
identifying novel substrates (5, 18, 36). The observation that some
C. burnetii Dot/Icm substrates bind to its own DotF further indicates
the high conservation between these two IVB secretion systems.
Our choice for “bait” (DotF) in the bacterial two-hybrid screen was
based primarily on studies with Legionella (5). However, a study by
Vincent et al. (15, 37) indicated that other Dot/Icm component
proteins, such as T4SS chaperones IcmS and IcmW, may be equally
promising baits for this type of screen. Our bioinformatics approach
achieved significant success in predicting C. burnetii type IV sub-
strates, as 26 of 42 predicted candidates were confirmed as Dot/Icm
substrates (Table S3). The high accuracy of this predictive approach
suggested that a significant number of the substrates’ homologs
(Table S6) and putative PmrA-regulated genes (Table S2) that were
not experimentally tested may also be Dot/Icm substrates. Consid-
ering that the number of predicted genes in C. burnetii is less than
Fig. 3. Development of a stably expressing RSF1010-based shuttle vector.
(A) Schematic map of the constructed RSF1010 shuttle vector pKM230. (B) Live
image of L929 cells infected by pKM230-transformed C. burnetii. Fluorescence
images for detection of mCherry expression (594nm) and DIC (60×) were taken
separately and merged. (C) Southern blot analysis of C. burnetii carrying
pKM230. Lane 1, genomic C. burnetii DNA, Lane 2, genomic DNA from C. bur-
netii transformed with pKM230. (D) C. burnetii pKM230 colony formation on
solid ACCM medium. Colonies were visible by microscopy (20×) after 3 d of in-
oculation (Upper), and pKM230-derived mCherry expression was visualized by
fluorescence microscopy (Lower). Arrows indicate single colony formation.
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70% of that of the L. pneumophila, it is surprising that C. burnetiimay
have more putative PmrA-regulated genes than L. pneumophila (17)
(126 vs. 35). Including previously described ankrin repeats containing
proteins (11, 14), there are 31 C. burnetii-confirmed Dot/Icm sub-
strates (Table S5) and five Dot/Icm proteins (Fig. 3) that contain
a putative PmrA consensus sequence, which represent more than
25% of predicted PmrA-regulated genes in C. burnetii. These ob-
servations suggest that the PmrA-PmrB two-component regulatory
system may play a critical role in regulating the physiology and
pathgenesis of C. burnetii, probably by controlling the assembly and
function of the T4SS. Validation of each putative PmrA-regulated
gene will be an important addition to our understanding of the reg-
ulation of pathogenic factors by this organism.
The recent progress in the study of pathogenic mechanisms used by
C. burnetii, particularly the recent development of a complex medium
for axenic culture of this bacterium and relevant in vitro and in vivo
models of Q fever, promise a rapid expansion in the analysis of T4SS
and its effectors during infections. Because of the paucity of genetic
tools, the activity of the C. burnetii Dot/Icm system has not been di-
rectly examined and some important L. pneumophila dot/icm genes
are absent in the C. burnetii genome (3), the fundamental question of
their role in infection has remained untested. Our demonstration that
the reporter protein β-lactamase fused with a Dot/Icm substrates was
translocated into host cells directly supports the functional assess-
ment of the C. burnetii T4SS. Although the fusion protein was stably
expressed after adding the CCF4-AM FRET substrate, it took con-
siderably longer for C. burnetii-infected samples to develop blue
fluorescence than those infected with Legionella. Many reasons, in-
cluding the intrinsic properties of the transporters, efficiency of
phagocytosis, and infection conditions, could account for these dif-
ferences. Nevertheless, the observation that both pathogens were
able to transfer the fusion protein in a manner that required the C-
terminal end of the substrate demonstrates that the C. burnetii Dot/
Icm system is active. With the development of mutagenesis systems
for C. burnetii with theHimar1 transposon (38), gene inactivation will
allow phenotypic characterization of specific mutants in this organ-
ism. It will be important to determine whether all of the Dot/Icm
proteins are essential for substrate translocation.
Like other highly adapted intracellular pathogens, many of the
C. burnetii Dot/Icm substrates contain motifs or structural features
specific for interaction with proteins of eukaryote origin. Indeed, the
presence of the ankyrin repeat domain was used to identify the first
C. burnetii Dot/Icm substrates (11). Accumulating evidence suggests
high-level conservation between the T4SS of L. pneumophila and
C. burnetii in structure and function in substrate translocation. That
only few substrates from these organisms display detectable simi-
larity further reflects their very different intracellular lifestyles and
the different hosts the bacteria associate with in the natural envi-
ronments. For examples, whereas C. burnetii needs to effectively
evade immune recognition by its hosts, L. pneumophila needs to be
highly adaptive to diverse amoebae hosts. Future work aiming at
revealing the biochemical and cell biological functions of these
substrates will validate the necessity of such differences.
Among the substrates identified in this study, 23 contain eukaryotic-
like domains implicated in protein–protein interaction (Table S5). For
example, 17 substrates harbor one or more coiled-coil domains (Table
S5), which are present in components of large protein complexes.
CBU1457 contains several tetratricopeptide repeats (TPRs), which are
3–16 repeated motifs of 34 amino acids known to mediate protein–
protein interactions. Moreover, the eukaryotic-like serine/threonine
protein kinase (STPK) domain is present in CBU0175 and CBU1397
(Table S5). These proteins may phosphorylate host targets to interfere
with signal transduction pathways. The identification of three proteins
(CBU0814, CBU1217, and CBUA0014) with an F-box motif suggests
that C. burnetii actively modulates host ubiquitination pathways, which
is a strategy shared by many bacterial pathogens, including L. pneu-
mophila (8–10), Salmonella enterica Typhimurium (39), and Shigella spp
(40). Interestingly, one Fic domain containing protein, which is in-
volved in posttranslational modification of target molecules by ampy-
lation (25, 41), has also been confirmed as a Dot/Icm substrate.
C. burnetii may have acquired these substrate genes by horizontal
gene transfer (42). In support of this notion, 14 of these 32 genes
(Table S5) have GC contents that are significantly (more that 10%)
different from the average GC content ofC. burnetii (42.7%). Despite
the high level similarity between the Dot/Icm systems of C. burnetii
and L. pneumophila, few substrates from these two organisms exhibit
significant homology (six of them are homologs, Table S2). Such low
similarity may result from the very different hosts (mammals vs. pri-
marily amoebae), in which the two pathogens have coevolved. Al-
ternatively, these effectors may have been acquired by convergent
evolution. Thus, although no homology was detected, some of the
proteins may have similar functional domains. In addition, similar
to the finding in L. pneumophila type IV substrates (5, 22), several
C. burnetii Dot/Icm substrates have more than one homolog in its
Fig. 4. C. burnetii has a functional secretion system and the C-terminal end of the substrate is important for efficient translocation. (A) TEM1 fusion proteins
were induced by IPTG in pCBTEM plasmids-transformed C. burnetii NMII strain. ACCM propagated C. burnetii variants were harvested and purified. Expression of
TEM1 fusion proteins was analyzed by Western blot. C burnetii surface antigen Com1 (CBU1910) was probed as loading control. Lane 1, C. burnetii/pCBTEM with-
out IPTG. Lane 2, C. burnetii/pCBTEMwith 1mM IPTG. Lane 3, C. burnetii/pCBTEM-CBU1825 with 1mM IPTG. Lane 4, C. burnetii/pCBTEM-CBU1825ΔC20 with 1 mM
IPTG. Lane 5,C. burnetii/pCBTEM-CBU1825C50with 1mM IPTG. (B and C) C. burnetiiNMII variants harboring the TEM1 fusion proteinswere used to infect THP-1 cells
at MOI 30, and TEM assay was performed as described inMaterials andMethods. Representative image from individual assays are shown on left. The percentage of
cells with an elevated 450 nm emission was measured by flow cytometry. Results shown represent the average of three to four independent experiments.
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genome (Table S6), which suggests that functional redundancy of
T4SS substrates may also exist in C. burnetii. Furthermore, except for
one protein (CBUA0014) encoded by a plasmid carried gene, only 18
substrates are fully conserved among C. burnetii isolates (Table S5),
a phenomenon in contrast to L. pneumophila, in which T4SS sub-
strates are highly conserved among different isolates of the same
species (43). The majority of missing homologs were presented as
pseudogenes in different isolates. There are 11 and 13 homologs
missing in chronic disease prototype isolates, K and G, respectively,
and 10 homologs are missing in the ancestral isolate, Dugway. This
supports the hypothesis that several conserved Dot/Icm substrates
play a key role in bacterial survival and that some group -pecific T4SS
substrates may participate in pathotype-specific virulence.
At present, it is difficult to determine which host pathways may be
hijacked by specific Dot/Icm substrate proteins. Nevertheless, spe-
cialized protein transfer systems and their substrates are important
in manipulating the cell biology of host cell. These T4SS effectors
may direct C. burnetii invasion, trafficking in the host cell, or modu-
lation and evasion of host cell functions. Future functional analysis
of effectors identified in this study should provide molecular mech-
anisms that account for the unique intracellular life cycle of this
important pathogen.
Materials and Methods
All L. pneumophila strains used in this study were derivatives of the Philadelphia
1 strain Lp02 (44). Bacteria were grown and maintained on CYE medium as pre-
viouslydescribed (45).Whennecessary, chloramphenicol (5μg/mL)andkanamycin
(20μg/mL)wereaddedto thecultures.C.burnetii strainNineMilephase II RSA439
(clone4)waspropagated in liquid acidified citrate cysteinemedium (ACCM)oron
semisolid ACCM agarose plates under 2.5% oxygen as previously described (31).
The bacterial strains used in this study are listed in Table S7. Details of plasmid
construction, bacteria purification and transformation, bacterial infection and
CyaA/TEM/SidC translocation assays, immunofluorescence assays,flow cytometry
analysis, and bioinformatic analysis are presented in SI Materials andMethods.
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